BR9607722A - Formulação transdérmica - Google Patents
Formulação transdérmicaInfo
- Publication number
- BR9607722A BR9607722A BR9607722A BR9607722A BR9607722A BR 9607722 A BR9607722 A BR 9607722A BR 9607722 A BR9607722 A BR 9607722A BR 9607722 A BR9607722 A BR 9607722A BR 9607722 A BR9607722 A BR 9607722A
- Authority
- BR
- Brazil
- Prior art keywords
- transdermal formulation
- transdermal
- formulation
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39044595A | 1995-02-17 | 1995-02-17 | |
US48101695A | 1995-06-07 | 1995-06-07 | |
PCT/US1996/001371 WO1996025154A1 (en) | 1995-02-17 | 1996-02-01 | Transdermal formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9607722A true BR9607722A (pt) | 1998-07-14 |
Family
ID=27013141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9607722A BR9607722A (pt) | 1995-02-17 | 1996-02-01 | Formulação transdérmica |
Country Status (22)
Country | Link |
---|---|
US (1) | US5858393A (pt) |
EP (1) | EP0727208B1 (pt) |
JP (1) | JPH11505513A (pt) |
KR (1) | KR19980702239A (pt) |
CN (1) | CN1181007A (pt) |
AR (1) | AR002027A1 (pt) |
AU (1) | AU700023B2 (pt) |
BR (1) | BR9607722A (pt) |
CA (1) | CA2212874A1 (pt) |
CO (1) | CO4700408A1 (pt) |
CZ (1) | CZ255097A3 (pt) |
DE (1) | DE69614419T2 (pt) |
ES (1) | ES2159683T3 (pt) |
FI (1) | FI973362A (pt) |
HU (1) | HUP9802070A3 (pt) |
IL (1) | IL116997A0 (pt) |
NO (1) | NO973715L (pt) |
NZ (1) | NZ302147A (pt) |
PE (1) | PE17897A1 (pt) |
TR (1) | TR199700799T1 (pt) |
WO (1) | WO1996025154A1 (pt) |
YU (1) | YU6196A (pt) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
US6417227B1 (en) | 1999-04-28 | 2002-07-09 | Cg And Associates | Methods of delivery of cetyl myristoleate |
AU1753301A (en) * | 1999-10-28 | 2001-05-08 | 3M Innovative Properties Company | Transdermal drug delivery devices |
EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
EP2275095A3 (en) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
US20070264130A1 (en) * | 2006-01-27 | 2007-11-15 | Phluid, Inc. | Infusion Pumps and Methods for Use |
US8986253B2 (en) * | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
WO2009143188A2 (en) * | 2008-05-19 | 2009-11-26 | Diperna Paul M | Disposable pump reservoir and related methods |
US7943187B2 (en) * | 2008-05-23 | 2011-05-17 | Bakr Rabie | Paeoniflorin preparations and uses thereof for fat reduction |
US20110097393A1 (en) * | 2008-06-25 | 2011-04-28 | US WorldMeade, LLC | Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
CA2737461A1 (en) * | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
EP3284494A1 (en) | 2009-07-30 | 2018-02-21 | Tandem Diabetes Care, Inc. | Portable infusion pump system |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4316893A (en) * | 1975-06-19 | 1982-02-23 | Nelson Research & Development Co. | Vehicle composition containing 1-substituted azacycloalkan-2-ones |
IT1233860B (it) * | 1988-02-08 | 1992-04-21 | Isf Spa | Derivati del peridroazacicloalca (1,2-a) imidazolo ad attivita' nootropa |
DK198590D0 (da) * | 1990-08-21 | 1990-08-21 | Novo Nordisk As | Heterocykliske forbindelser, deres fremstilling og anvendelse |
US5238933A (en) * | 1991-10-28 | 1993-08-24 | Sri International | Skin permeation enhancer compositions |
NZ271313A (en) * | 1993-08-19 | 1999-09-29 | Novo Nordisk As | Pharmaceutical use of oxa-or thia-diazole-substd. azabicyclic ring compounds |
-
1996
- 1996-01-30 PE PE1996000071A patent/PE17897A1/es not_active Application Discontinuation
- 1996-02-01 EP EP96300710A patent/EP0727208B1/en not_active Expired - Lifetime
- 1996-02-01 CN CN96193122A patent/CN1181007A/zh active Pending
- 1996-02-01 KR KR1019970705636A patent/KR19980702239A/ko not_active Application Discontinuation
- 1996-02-01 IL IL11699796A patent/IL116997A0/xx unknown
- 1996-02-01 NZ NZ302147A patent/NZ302147A/xx unknown
- 1996-02-01 DE DE69614419T patent/DE69614419T2/de not_active Expired - Fee Related
- 1996-02-01 BR BR9607722A patent/BR9607722A/pt not_active Application Discontinuation
- 1996-02-01 HU HU9802070A patent/HUP9802070A3/hu unknown
- 1996-02-01 CZ CZ972550A patent/CZ255097A3/cs unknown
- 1996-02-01 ES ES96300710T patent/ES2159683T3/es not_active Expired - Lifetime
- 1996-02-01 WO PCT/US1996/001371 patent/WO1996025154A1/en not_active Application Discontinuation
- 1996-02-01 TR TR97/00799T patent/TR199700799T1/xx unknown
- 1996-02-01 CA CA002212874A patent/CA2212874A1/en not_active Abandoned
- 1996-02-01 AR ARP960101246A patent/AR002027A1/es not_active Application Discontinuation
- 1996-02-01 YU YU6196A patent/YU6196A/sh unknown
- 1996-02-01 AU AU47742/96A patent/AU700023B2/en not_active Ceased
- 1996-02-01 JP JP8524982A patent/JPH11505513A/ja active Pending
- 1996-02-01 CO CO96004314A patent/CO4700408A1/es unknown
-
1997
- 1997-08-12 NO NO973715A patent/NO973715L/no unknown
- 1997-08-15 FI FI973362A patent/FI973362A/fi unknown
- 1997-08-25 US US08/918,141 patent/US5858393A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5858393A (en) | 1999-01-12 |
IL116997A0 (en) | 1996-06-18 |
NO973715D0 (no) | 1997-08-12 |
DE69614419T2 (de) | 2002-05-23 |
JPH11505513A (ja) | 1999-05-21 |
HUP9802070A3 (en) | 2000-09-28 |
FI973362A0 (fi) | 1997-08-15 |
PE17897A1 (es) | 1997-06-12 |
HUP9802070A2 (hu) | 1999-02-01 |
AU700023B2 (en) | 1998-12-17 |
CO4700408A1 (es) | 1998-12-29 |
MX9706143A (es) | 1997-11-29 |
WO1996025154A1 (en) | 1996-08-22 |
YU6196A (sh) | 1998-09-18 |
EP0727208A1 (en) | 1996-08-21 |
CA2212874A1 (en) | 1996-08-22 |
TR199700799T1 (xx) | 1998-02-21 |
AR002027A1 (es) | 1998-01-07 |
CN1181007A (zh) | 1998-05-06 |
NZ302147A (en) | 1998-10-28 |
KR19980702239A (ko) | 1998-07-15 |
AU4774296A (en) | 1996-09-04 |
NO973715L (no) | 1997-08-12 |
FI973362A (fi) | 1997-08-15 |
CZ255097A3 (en) | 1997-12-17 |
EP0727208B1 (en) | 2001-08-16 |
ES2159683T3 (es) | 2001-10-16 |
DE69614419D1 (de) | 2001-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69634256D1 (de) | Zementformulierung | |
DE69627539D1 (de) | Verpackungsfreie bioelektrode | |
DK1093815T3 (da) | Oral 2-methyl-thieno-benzodiazepinformulering | |
ID25533A (id) | Formulasi 2-metil-tieno-benzodiazepin | |
NO962381L (no) | Spiss-beskytter-innretning | |
DE69621528D1 (de) | Anti-inflamatorische agenzien | |
DE59602881D1 (de) | Sollwertgeber | |
PT828506E (pt) | Agentes endoparasiticidas | |
NO981008D0 (no) | Farmasöytisk formulering | |
PT778023E (pt) | Agentes neuroprotectores | |
NO973471D0 (no) | Transdermal formulering | |
BR9607058A (pt) | Composição | |
BR9606809A (pt) | Composição inseticidamente ativa | |
ATA181095A (de) | Probiotisch wirksame formulierung | |
BR9607722A (pt) | Formulação transdérmica | |
PT728814E (pt) | Composicao betuminosa | |
BR9609903A (pt) | ComposiçÃo inseticidamente ativa | |
IL116999A0 (en) | Transdermal formulation | |
DE69631378D1 (de) | Pestizide formulierung | |
DE69616374D1 (de) | Germizide zusammensetzung | |
DE69430362D1 (de) | Ektoparasitizide formulierung | |
FI973230A0 (fi) | Uusi farmaseuttinen formulaatio | |
BR9607946A (pt) | Composição | |
FI954547A0 (fi) | Asemointilaite | |
SE9500036D0 (sv) | Formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
FA8 | Dismissal: dismissal - article 36, par. 1 of industrial property law |